Hong Kong Logistics Stock News

REPT BATTERO Energy (SEHK:666) has just posted its FY 2025 first half numbers, with revenue of C¥9.5b and a basic EPS loss of C¥0.03, alongside trailing twelve month revenue of C¥24.3b and EPS of C¥0.27 that reflects the recent move into profitability. The company has seen revenue step up from C¥7.6b in 2024 H1 to C¥9.5b in 2025 H1 and C¥10.2b in 2024 H2 on a reported basis. Basic EPS has moved from a loss of C¥0.19 in 2024 H1 and a loss of C¥0.32 in 2024 H2 to a smaller loss of C¥0.03 in the...

Yip's Chemical Holdings (SEHK:408) has reported its FY 2025 first half with revenue of HK$1,430.4 million and basic EPS of HK$0.12, set against a trailing twelve month net income of HK$137.4 million and EPS of HK$0.25, where earnings grew 41.8% over the past year. The company has seen revenue move from HK$1,557.4 million in 1H FY 2024 to HK$1,605.0 million in 2H FY 2024 and HK$1,430.4 million in 1H FY 2025, while net income excluding extra items went from HK$34.1 million to HK$62.8 million...

Hua Medicine (Shanghai) (SEHK:2552) has reported FY 2025 first half revenue of C¥217.4 million and basic EPS of C¥1.20, marking a clear break from the losses seen a year earlier when basic EPS was C¥0.15 and revenue was C¥102.7 million. Over the past three half year periods, revenue has moved from C¥102.7 million in 1H 2024 to C¥153.2 million in 2H 2024 and then to C¥217.4 million in 1H 2025. Over the same span, trailing twelve month basic EPS has shifted from a loss of C¥0.25 in 2H 2024 to a...

Liaoning Port (SEHK:2880) has posted its FY 2025 numbers with fourth quarter revenue of C¥2.9b and basic EPS of C¥0.000276, rounding out a trailing twelve month revenue base of C¥11.4b and EPS of C¥0.054807. Over recent quarters the company has seen revenue move from C¥3.1b in Q4 2024 to C¥2.9b in Q4 2025, while quarterly EPS shifted from C¥0.008271 to C¥0.000276. This sets a backdrop to the reported 14.2% earnings growth over the last year and an 11.5% trailing net margin versus 10.3% a year...

Peijia Medical (SEHK:9996) has reported FY 2025 first half results with revenue of C¥353.38 million and a basic EPS loss of C¥0.104926, alongside net income excluding extra items of a C¥69.88 million loss that keeps profitability in focus for investors. The company has seen revenue move from C¥301.20 million in 1H 2024 to C¥353.38 million in 1H 2025, while basic EPS stayed at roughly a C¥0.10 loss and trailing 12 month net income excluding extra items sits at a C¥203.29 million loss. The key...

Shanghai HeartCare Medical Technology (SEHK:6609) has just posted its FY 2025 results, with first half revenue at C¥185.5 million and basic EPS of C¥1.34, while trailing twelve month revenue sits at C¥408.3 million and EPS at C¥2.21 as the business turned profitable over the past year. The company has seen revenue move from C¥128.5 million in the first half of 2024 to C¥149.4 million in the second half of 2024 and then to C¥185.5 million in the first half of 2025. This has come alongside a...

Nissin Foods (SEHK:1475) has just wrapped up FY 2025 with fourth quarter revenue of HK$939 million and basic EPS of HK$0.07, alongside trailing twelve month revenue of HK$4.0 billion and EPS of HK$0.32 that reflect a 64.9% earnings increase over the last year. Over recent periods, revenue has ranged from HK$859 million in Q2 FY 2024 to HK$1.07 billion in Q1 FY 2025. Quarterly EPS has moved between HK$0.04 and HK$0.11, setting up a story where recent margin gains and an 8.3% net profit margin...

Excellence Commercial Property & Facilities Management Group (SEHK:6989) opened FY 2025 with first half revenue of C¥1,996.2 million and basic EPS of C¥0.12, setting the tone for another period where topline scale contrasts with tighter profitability. Over the last three reported halves, revenue has moved from C¥2,063.1 million in 1H 2024 to C¥2,149.8 million in 2H 2024 and C¥1,996.2 million in 1H 2025. Over the same period, basic EPS shifted from C¥0.14 to C¥0.12 and then C¥0.12 again,...

Mabpharm (SEHK:2181) has reported its FY 2025 first half results with revenue of C¥274.2 million and basic EPS of C¥0.000702, while trailing 12 month figures show revenue of C¥646.1 million and basic EPS of C¥0.01 as the business moves through its first year of profitability. Over the past reported periods, revenue has shifted from C¥108.5 million in 1H FY 2024 to C¥149.7 million in 2H FY 2024 and then to C¥274.2 million in 1H FY 2025, with net income moving from a loss of C¥97.6 million in...

Zhou Hei Ya International Holdings (SEHK:1458) has opened FY 2025 with first half revenue of C¥1.22b and basic EPS of C¥0.053, setting the tone against a trailing twelve month picture that shows revenue of C¥2.54b and basic EPS of about C¥0.08. Over recent periods the company has seen revenue move from C¥1.26b in 1H 2024 to C¥1.19b in 2H 2024 and C¥1.22b in 1H 2025. Over the same intervals, basic EPS shifted from C¥0.015 to C¥0.030 and then to C¥0.053, giving investors a fresh read on how...

Shougang Fushan Resources Group (SEHK:639) has released its FY 2025 first half numbers, reporting revenue of HK$2,101.4 million and basic EPS of HK$0.079, with net income of HK$404.1 million setting the tone for the period. Over the last three reported halves, revenue has moved from HK$2,531.6 million and EPS of HK$0.170 in 1H 2024 to HK$2,559.2 million and EPS of HK$0.131 in 2H 2024, before landing at the latest 1H 2025 figures. With net profit margin sitting at 12.5% versus 29.5% a year ago...

JF SmartInvest Holdings (SEHK:9636) has reported FY 2025 results with first half revenue of C¥2.1b and basic EPS of C¥1.96, backed by trailing twelve month revenue of C¥3.4b and EPS of C¥2.05 as the headline earnings numbers investors are weighing against last year. Over the past reported halves, revenue has moved from C¥898.1m in 1H 2024 to C¥1.41b in 2H 2024 and then to C¥2.1b in 1H 2025, while EPS has shifted from a loss of C¥0.40 in 1H 2024 to C¥1.03 in 2H 2024 and C¥1.96 in 1H 2025. This...

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ( HKG:6990 ) just released its full-year report and things are...

Why CNOOC Shares Are Back on Investors' Radar CNOOC (SEHK:883) has caught investor attention again, with the share price moving 2.5% over the past day and showing double digit returns over the past month and past 3 months. See our latest analysis for CNOOC. That 2.5% 1 day share price gain sits within a strong upswing, with a 30 day share price return of 14.23%, a 90 day share price return of 41.84%, and a 1 year total shareholder return of 68.17%. This points to building momentum rather than...

Last week's earnings announcement from Pacific Basin Shipping Limited ( HKG:2343 ) was disappointing to investors, with...

As you might know, China Telecom Corporation Limited ( HKG:728 ) last week released its latest full-year, and things...

Investors in Green Tea Group Limited ( HKG:6831 ) had a good week, as its shares rose 4.1% to close at HK$7.90...

China Petroleum & Chemical Corporation ( HKG:386 ) missed earnings with its latest annual results, disappointing...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Investors in Yihai International Holding Ltd. ( HKG:1579 ) had a good week, as its shares rose 9.1% to close at...

The market wasn't impressed with the soft earnings from BOC Aviation Limited ( HKG:2588 ) recently. We did some...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Nongfu Spring Co., Ltd. ( HKG:9633 ) just released its yearly report and things are looking bullish. The company beat...